Author:
Weng Xiaoling,Zhang Hong,Ye Junyi,Kan Mengyuan,Liu Fatao,Wang Ting,Deng Jiaying,Tan Yanfang,He Lin,Liu Yun
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).
2. Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 355, 11–20, doi:10.1056/NEJMoa055531 (2006).
3. Patel, R. & Leung, H. Y. Targeting the EGFR-family for therapy: biological challenges and clinical perspective. Curr. Pharm. Des. 18, 2672–2679 (2012).
4. Ettinger, D. S. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer. Oncologist 11, 358–373, doi:10.1634/theoncologist.11-4-358 (2006).
5. Berg, M. & Soreide, K. EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy. Discov. Med. 14, 207–214 (2012).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献